Lv2
130 积分 2024-01-03 加入
Respiratory syncytial virus (RSV): recent advances in preventative strategies and visions for the future
4天前
已完结
Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study
27天前
已完结
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
27天前
已完结
Burden of infection and hospitalization from respiratory syncytial virus-associated acute lower respiratory tract infections in Chinese children: Modeling of national, regional, and provincial estimates
1个月前
已完结
Burden of infection and hospitalization from respiratory syncytial virus-associated acute lower respiratory tract infections in Chinese children: Modeling of national, regional, and provincial estimates
1个月前
已关闭
Current state and challenges in respiratory syncytial virus drug discovery and development
1个月前
已完结
Risk Factors and Clinical Prognosis Associated With RSV-ALRI Intensive Care Unit Admission in Children
2个月前
已完结
Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2个月前
已完结
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
2个月前
已完结
Molecular surveillance in the nirsevimab era: lessons from respiratory syncytial virus breakthrough infections
2个月前
已完结